Addressing Unmet Needs in Oncology Clinical Research

This document is a report that outlines the challenges and unmet needs faced by oncology trial sponsors in clinical research. It details the findings from a market needs assessment survey conducted with over 140 global clinical outsourcing decision-makers in oncology. The report emphasizes the importance of midsize Contract Research Organizations (CROs) like Worldwide Clinical Trials, which are perceived to offer more stability and personalized solutions compared to larger CROs. The document highlights key concerns such as complex study protocols, project team disruption, and the need for effective communication and collaboration. It also presents Worldwide's strengths in project management quality and operational excellence, as recognized in the ISR Reports’ Phase II/III CRO Benchmarking Report. The report concludes by discussing how Worldwide's tailored approach and expertise can address the specific needs of oncology sponsors, ultimately enhancing the overall clinical trial experience.